Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series

Journal of the American Geriatrics Society

Volumn 47, Issue 5, 1999, Pages 564-569

  Lim, Alfredo ^a   Tsuang, Debby ^a,b,c   Kukull, Walter ^a   Nochlin, David ^a   Leverenz, James ^a,b   McCormick, Wayne ^a   Bowen, Jim ^a   Teri, Linda ^b   Thompson, Jill ^a   Peskind, Elaine R ^a,b   Raskind, Murray ^a,b   Larson, Eric B ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Alzheimer's disease; Clinico neuropathological; Community sample; Diagnosis

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CLINICAL EXAMINATION; COMMUNITY CARE; CORRELATION FUNCTION; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY;

EID: 0032962568     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1999.tb02571.x     Document Type: Article

References (32)

1. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42: 1097-1105.
2. Mirra SS, Heyman A, Mckeel D et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
3. Kazee AM, Eskin TA, Lapham LW et al. Clinicopathologic correlates in Alzheimer disease: Assessment of clinical and pathologic diagnostic criteria. Alzheimer Dis Assoc Disord 1993;7:152-164.
4. Barnhart RL, vanBelle G, Edland SD et al. Geographically overlapping Alzheimer's disease registries: Comparisons and implications. J Geriatr Psychiatry Neurol 1995;8:203-208.
5. McKhann G, Drachman D, Folstein M et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
6. Larson EB, Kukull WA, Teri L et al. University of Washington Alzheimer's Disease Patient Registry (ADPR): 1987-1988. Aging 1990;2:404-408.
7. Kukull WA, Hinds TR, Schellenberg GD et al. Increased platelet membrane fluidity as a diagnostic marker for Alzheimer's disease: A test in population-based cases and controls. Neurology 1992;42:607-614.
8. Coblentz JM, Mattis S, Zingesser LH et al. Presenile dementia: Clinical aspects and evaluation of cerebrospinal fluid dynamics. Arch Neurol 1973;29: 229-308.
9. Wechsler D. A standardized memory scale for clinical use. J Psychol 1945; 19:87-95.
10. Fuld PA. Fuld Object-Memory Evaluation. Illinois: Stoetling Company, 1977.
11. Halstead WC, Wepman JM. The Halstead-Wepman aphasia screening test. J Speech Hear Dis 1959;14:9-15.
12. Wechsler D. Wechsler Adult Intelligence Scale-Revised Manual. New York: The Psychological Corporation, 1981.
13. Reitan RM. Validity of the trail-making test as an indication of organic brain damage. Percept Mot Skill 1958;8:271-276.
14. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;12:189-198.
15. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral gray matter of elderly subjects. Br J Psychiatry 1968;114:797-811.
16. Nochlin D, Mackenzie AP, Bryant EM et al. A simple method of rapid freezing adequately preserves brain tissue for immunocytochemistry, light and electron microscopic examination. Acta Neuropathol 1993;86:645-650.
17. McKeith IG, Galasko D, Kosaka K et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
18. Rasmusson DX, Brandt J, Steele C et al. Accuracy of clinical diagnosis of Alzheimer disease and clinical features of patients with non-Alzheimer disease neuropathology. Alzheimer Dis Assoc Disord 1996;10:180-188.
19. Victorhoff J, Mack WJ, Lyness SA, Chui HC. Multicenter clinicopathological correlation in dementia. Am J Psychiatry 1995;152:1476-1484.
20. Tsuang D, Kukull W, Sheppard L et al. Impact of sample selection on APOE e4 allele frequency: A comparison of two Alzheimer's disease samples. J Am Geriatr Soc 1996;44:704-707.
21. Larson EB, Edwards JK, O'Meara E et al. Neuropathologic diagnostic outcomes from a cohort of outpatients with suspected dementia. J Gerontol 1996;51A:M313-318.
22. Molsa PK, Paljarvi L, Rinne JO et al. Validity of clinical diagnosis in dementia: A prospective clinicopathological study. J Neurol Neurosurg Psychiatry 1985;48:1085-1090.
23. Wade JP, Mitsen TR, Hachinski VC et al. The clinical diagnosis of Alzheimer's disease. Arch Neurol 1987;44:24-29.
24. Leverenz J, Sumi S. Parkinson's disease in patients with Alzheimer's disease. Arch Neurol 1986;43:662-664.
25. Gearing M, Mirra SS, Hedreen JC et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 1995;45:461-466.
26. Klatka LA, Schiffer RB, Powers JM, Kazee AM. Incorrect diagnosis of Alzheimer's disease: A clinicopathologic study. Arch Neurol 1997;53:35-42.
27. Hofman A, Ott A, Breteler MM et al Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997;349:151-154.
28. Snowdon DA, Greiner LH, Mortimer JA et al. Brain infarction and the clinical expression of Alzheimer disease: The Nun Study. JAMA 1997;277:813-817.
29. Dickson DW, Davies P, Bevona C et al. Hippocampal sclerosis: A common pathological feature of dementia in very old (≥ 80 years of age) humans. Acta Neuropathol 1994;88:212-221.
30. Corey-Bloom J, Sabbagh MN, Bondi MW et al. Hippocampal sclerosis contributes to dementia in the elderly. Neurology 1997;48:154-160.
31. Stergachis A. Group Health Cooperative of Puget Sound. In: BL Storm, ed. Pharmacoepidemiology. New York: Churchill Livingstone, 1989, pp 149-160.
32. Consensus recommendation for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 1997;18(4 Suppl):S1-2.